Ralliant Corporation – Navigating a Turnaround in a Challenging Specialty Chemicals Market

Ralliant Corporation is a diversified specialty chemicals and advanced materials manufacturer supplying engineered polymers, coatings, and adhesives to aerospace, automotive, and industrial customers. The company generates revenue through a direct sales model supported by a global technical service network, with approximately 60% of revenue derived from long-term supply agreements. Ralliant operates 14 manufacturing facilities across North America, Europe, and Asia, serving over 2,000 active customers, none of which represents more than 10% of total revenue. The company employs roughly 6,000 people and generates annual revenue of approximately $2.1B. Recent restructuring efforts have streamlined operations, with the divestiture of its commodity chemicals division completed in Q2 2026 for $850M in gross proceeds.

• Near-Term (FY2026–FY2027): The company is guiding to 3–5% organic revenue growth driven by aerospace aftermarket recovery and new program wins in electric vehicle battery enclosures. The launch of a new high-temperature polymer line in Q3 2026 is expected to contribute $50M in annualized revenue by mid-2027, with gross margins 500 basis points above the corporate average.
• Medium-Term (FY2028–FY2030): Management targets 7–9% revenue CAGR driven by expansion into semiconductor manufacturing materials and green hydrogen infrastructure components. The company has secured $120M in government grants for a new facility in Ohio, expected to come online in 2028. Additionally, the shift toward circular economy solutions — including recycled-content polymers — positions Ralliant to capture a share of the projected $25B sustainable materials market by 2030.
• Margin Expansion: The combination of mix-shift toward specialty products, operational leverage, and procurement savings is expected to drive adjusted EBITDA margins from 12% in FY2025 to 18% by FY2028, supported by a $200M cost-out program announced in January 2026.

The FY2025 reported loss of $1.21B includes $890M in goodwill impairment charges and $240M in restructuring costs, explaining the negative trailing EPS of -$10.93. Revenue declined 11% in FY2025 due to the divestiture of the commodity chemicals unit and softer industrial demand. We expect stabilization in FY2026 with flattish revenue, followed by a return to growth as new product launches ramp. The path to profitability is gradual, with adjusted EPS turning positive in FY2028, driven by margin expansion and reduced interest expense following debt paydown.

The global specialty chemicals market is valued at approximately $850B, with the advanced materials segment — Ralliant’s core focus — representing about $120B and growing at 5% annually. The competitive landscape is fragmented but dominated by larger players with broader portfolios. Ralliant’s competitive positioning is strongest in high-temperature polymers for aerospace, where it holds an estimated 15% market share, and in specialty adhesives for automotive lightweighting, where it ranks in the top five globally.

Ralliant trades at a premium EV/EBITDA multiple to its peers, reflecting the market’s expectation for successful margin convergence. However, the company’s smaller scale and higher leverage justify a discount on a relative basis. Key competitive advantages include proprietary polymer chemistries protected by 450 active patents and deep customer relationships with long qualification cycles that create high switching costs.

Our valuation methodology triangulates a discounted cash flow (DCF) analysis and comparable company multiples to derive a 12-month price target.

DCF Summary: We project unlevered free cash flow reaching $250M by FY2028, growing at 3% terminal growth. Applying a 10.5% WACC (reflecting a beta of 1.3, 45% equity weight, and 5.5% after-tax cost of debt) and a 3% terminal growth rate yields a net present value of $8.2B. Adding the $350M present value of net operating loss carryforwards and subtracting $2.1B in net debt gives an equity value of $6.45B, or $58.30 per share.

Comparable Valuation: Applying the peer average forward EV/EBITDA of 9.2x to our FY2026E EBITDA of $285M yields an enterprise value of $2.6B — clearly mispricing the company’s growth potential. Using the sector median of 10.5x on FY2027E EBITDA of $330M yields an enterprise value of $3.5B, which is below the current market cap, suggesting the market is already pricing in FY2028E metrics.

Our blended valuation of $46.40 suggests the current price of $67.31 already embeds substantial optimism. The market appears to be pricing in successful execution of the turnaround with limited margin for error.

• Execution Risk: The restructuring program is complex, involving facility closures, supply chain reconfiguration, and customer re-qualification. Any delays in achieving the $150M cost savings target or disruptions to customer supply could result in revenue attrition exceeding current projections.
• Cyclicality Exposure: Aerospace and automotive markets are highly cyclical. A recession in 2027, as some economists forecast, could delay the recovery in these end-markets and push the company’s return to profitability further out.
• Raw Material Cost Inflation: The company’s gross margins are sensitive to petrochemical feedstock prices. Sustained oil price increases could compress margins by 150–200 basis points, offsetting the benefits of operational leverage.
• Customer Concentration in Development Programs: Ralliant is investing heavily in new programs for EV battery enclosures and semiconductor materials. If key development programs are delayed or cancelled by OEM customers, the anticipated revenue contribution may not materialize.
• Regulatory and Environmental Liabilities: As a chemicals manufacturer, Ralliant faces potential liabilities under evolving PFAS and other environmental regulations. A worst-case scenario involving remediation costs could require significant capital allocation away from growth initiatives.